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ABSTRACT
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer worldwide. Metastasis of HCC to the heart is rare 
with prevalence on autopsy of less than 6%. There is still limited study evaluated the metastasis of hepatocellular 
carcinoma to the heart. The aim of this study is to know the prevalence and characteristic of metastasis of HCC to the 
heart in Indonesia. This retrospective study was conducted in secondary referral hospital in Tangerang county, 
Indonesia. We evaluated from medical record included baseline characteristic, survival and treatment of HCC and 
echocardiogram data for diagnosing metastasis to the heart from 2013-2015. There were 5 HCC patients recorded in the 
last 3 years. All patients were male with median age 56(53-61) years old. Four patients were diagnosed using 
transthoracic echocardiograph and the rest using multi sliced CT scan. All patients were having continuous thrombus 
from inferior cava vein until right atrial. For the conclusion Hepatocellular carcinoma were reported as the cause of 
intra-heart metastases in Indonesia. All patients were in late stage. 
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ABSTRAK
Karsinoma hepatoselular adalah kanker keenam terbanyak di seluruh dunia. Metastasis karsinoma hepatoselular ke 
jantung jarang, prevalensi yang ditemukan pada otopsi kurang dari 6 persen. Masih amat jarang studi yang mengevaluasi 
metastasis karsinoma hepatoselular ke jantung. Tujuan dari studi ini adalah ingin mengetahui prevalensi dan 
karakteristik metastasis karsinoma hepatoselular ke Jantung di Indonesia. Studi retrospektif ini dilakukan di rumah sakit 
rujukan tipe B di daerah Tangerang, Indonesia. Kami mengevaluasi dari rekam medis, meliputi karaktersitik dasar, 
kesintasan, dan terapi karsinoma hepatoselular; serta data ekokardiografi untuk mendiagnosis metastasis ke jantung 
dari 2013-2015. Terdapat 5 pasien hepatoselular karsinoma pada 3 tahun terakhir. Semua pasien laki-laki dengan usia 
median 56 (53-61) tahun. Empat pasien terdiagnosis menggunakan ekokardiografi trans torakal dan sisanya 
menggunakan CT scan. Semua pasien memiliki trombus kontinu dari vena cava inferior hingga atrium kanan. Sebagai 
simpulan, karsinoma hepatoselular dilaporkan sebagai penyebab metastasis ke jantung di Indonesia. Semua pasien 
datang pada stadium lanjut.
Kata Kunci: Jantung, karsinoma hepatosellular, metastasis
INTRODUCTION
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer (749 000 new cases) worldwide.1 The incidence varies from 3 out of 100 000 in Western 
countries, to more than 15 out of 100 000 in certain areas of the world.2 Most of 
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the liver with HCC was complicated by cirrhosis. 
Cirrhosis is the cause of portal hypertension and 
liver failure. Hepatitis B and C are the most common 
cause of Liver cirrhosis and HCC in developing 
countries especially in Indonesia. The prevalence 
of HCC in future will be increasing linear to the 
increasing of hepatitis B and C infections.1 
Heart tumors are classified into primary benign 
or malignant tumors that arise from the heart or 
into secondary, metastatic tumors that invade the 
heart. Metastasis of HCC to the heart is rare with 
prevalence on autopsy of less than 6%. This 
metastasis is presumed to be caused by tumor 
thrombi infiltrating the hepatic vein, at which point 
they are disseminating by hepatic blood flow to the 
right ventricle of the heart and rarely by direct 
extension. Portal vein, hepatic vein and the inferior 
vena cava are often affected. Symptoms such as 
sudden dyspnoe or resistant lower extremity edema, 
syncope and palpitations are generally seen in HCC 
patients with intra-heart involvement.3-5 
Several case reports have been reported 
metastasis HCC to the heart. There is still limited 
study evaluated the metastasis of hepatocellular 
carcinoma to the heart. The aim of this study is to 
know the prevalence and characteristic of metastasis 
of HCC to the heart in Indonesia.
MATERIAL AND METHODS
This retrospective study was conducted in 
secondary referral hospital in Tangerang county, 
west part of Jakarta, capital city of Indonesia. We 
evaluated from medical record included baseline 
characteristic of, survival and treatment of HCC and 
echocardiogram data for diagnosing metastasis to 
the heart from 2013-2015. The definition of HCC 
was from 3 phase abdominal Computed Tomography 
(CT) scan. The Barcelona Clinical Liver Cancer staging 
was used to stage the HCC. The presence of cirrhosis, 
Child T. Pugh grade, characteristic and survival of 
HCC patients were recorded. Clinical symptoms 
related to heart problem also recorded to be 
evaluated. Electrocardiogram (ECG) and echocardiogram 
data and characteristic were analyzed if there were 
related to clinical symptoms. The invasion of tumor 
to right atrial or ventricle was defined as presence 
of tumor or tumor emboli in right atrial and ventricle. 
RESULTS
There were 5 HCC patients recorded in the last 
3 years. All patients were male with median age 56 
(53-61) years old. Three patients had tumor in right 
atrial and the others 2 patients had tumor in right 
ventricle. Four patients were diagnosed using 
transthoracic echocardiograph and the rest using 
multi sliced CT scan. All patients were having 
continuous thrombus from inferior cava vein until 
right atrial. All patients were recorded died just 
several weeks after diagnosed. Four patients with 
tumor in right ventricle had heart failure symptoms. 
All patients did not have ECG abnormalities. No 
arrhythmias symptoms and sign were reported. All 
patients had liver cirrhosis as the background of 
HCC. Three patients had B classifications of CTP. 
And the others had C classifications of CTP. All 
patients identified had chronic hepatitis B infections 
as the cause of liver cirrhosis. Two patients had 
portal vein thrombosis involvement. 
DISCUSSION
Despite being the sixth most prevalent cancer 
worldwide, HCC seldom metastasizes to the heart. 
Such events are rare with a prevalence of less than 
6% in one case series of autopsied patients with 
known HCC. It is estimated that 5-10% of patients 
with HCC will develop some form of heart metastasis. 
Metastasis of HCC into heart cavity is mainly caused 
by direct invasion of the Inferior Vena Cava (IVC) 
and extension into the right atria. Right ventricle 
metastasis without IVC and RA metastasis is rarely 
reported and may be caused by hematogenous 
spread of cancer cells.6
In our study there were 5 HCC patients with 
heart metastasis identified in the last 3 years 
retrospective study. Two patients found having tumor 
in inferior cava vein. These suggest the metastases 
reach the heart via the hemato-genous route or 
trans-venous extension. Extra heart tumors may 
also reach the atria and even the chambers of the 
heart by trans-venous extension. Futhermore, HCC 
has been observed to extend through the inferior 
cava vein.6 
Four of 5 patients had heart failure symptoms 
and were diagnosed having metastasis to right atria 
and ventricle using transthoracic echocardiography. 
Heart metastases usually remain clinically silent 
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particularly as the vast majority of heart metastases 
are small. In retrospective studies, only about one-
tenth of patients who died of tumor disease and 
showed heart spread as identified at post mortem 
examination presented with symptoms indicating 
of heart involvement.7
Usually metastases to the heart are detected 
during initial tumor staging. On the other hand, 
they may not become clinically seen until many 
years after cancer diagnosis. Heralds of metastases 
to the heart are a rapid increase in heart size by 
pericardial effusion, new signs of heart failure or 
valve disease, conduction defects, and atrial or 
ventricular heart rhythm disturbances. Symptoms 
such as dyspnoe or tachypneu, and clinical findings 
such as systolic heart murmur, peripheral edema, 
plural or pericardial effusion, or ascites are usually 
reported.8–11
The electrocardiographic (ECG) recordings are 
usually unspecific but many document possible 
ventricular of supraventricular arrhythmias or 
conduction defects. All of our patients did not show 
ECG abnormalities. Pericardial effusion can cause 
low voltage and electrical alternans. Q-waves can 
be found as residues of tumor-related myocardial 
infarction; an ECG view of infarction can also result 
from infiltration of myocardium by the metastases.8–11
Chest radiography abnormalities found in 
metastases to the heart are an increase in 
heartsilhouette through pericardial effusion or peri 
and/or paracardial tumor growth, as well as a pleural 
effusion resulting from heart failure. In the cases 
of larger size, intra-cavitary may appear as filling 
defects under radionuclide or contrast medium 
angiography. Method of choice to detect heart 
metastases and their complications is two-
dimensional echocardiography. Echocardiography 
can show dense pericardial bands reflecting the 
pericardium being thickening by inflammation or 
tumor infiltration.8-11 
In cases of larger myocardial metastases, regional 
wall motion abnormalities can be revealed by 
ultrasound. Intra-cavitary lessions can also be 
detected by high sensitivity. In the case of pericardial 
lesion the transesophageal approach is superior to 
the transthoracic approach. Four of five our patients 
were visualized using transthoracic echocardiographic 
approach. The others diagnostic imaging methods 
are computer tomography (CT) and magnetic 
resonance imaging. Size and extension of paracardial 
tumor growth can be determined more precisely 
than by sonography. One patient found accidently 
by CT when he was evaluated for staging of HCC. 
That patient found tumor infiltration from inferior 
cava vein into right atria.11
In the most cases heart metastases manifest in 
patients with advanced tumor disease with the heart 
being involved in the generalized tumor spread. At 
this stage of disease, many patients will already 
have undergone surgical treatment for the tumor 
of origin or radio- or chemotherapy. In our cases 
mostly HCC patients were diagnosed in inoperable 
cases. Most of cases in Indonesia were undergone 
trans-arterial chemo-embolization or radiotherapy. 
In our cases all patients were in inoperable cases 
and only supportive care could be done because of 
bad performances status. In the cases of pericardial 
involvement may be diminished by local radiotherapy 
or systemic chemotherapy. Heart tamponade makes 
percutaneous pericardiocentesis should be done as 
soon as possible.11 
CONCLUSION
Hepatocellular carcinoma were reported as the 
cause of intra-heart metastasis in our county. All 
patients were in late stage. 
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